Elevar Drug Patent Portfolio

Elevar owns 1 orange book drug protected by 2 US patents Given below is the list of Elevar's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12152034 Fgfr Inhibitors And Methods Of Making And Using The Same 18 Nov, 2041
Active
US11780845 Fgfr Inhibitors And Methods Of Use Thereof 12 May, 2040
Active


Elevar's Family Patents


Family Patents



Elevar Drug List

Given below is the complete list of Elevar's drugs and the patents protecting them.


1. Lyrfigtu

Lyrfigtu is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12152034 Fgfr Inhibitors And Methods Of Making And Using The Same 18 Nov, 2041
(15 years from now)
Active
US11780845 Fgfr Inhibitors And Methods Of Use Thereof 12 May, 2040
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lyrfigtu's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List